Taiwan FDA registration 044c0eb9032f46f884138bad11f31f33

The Binding Site Optilite Caeruloplasmin Kit

TW: 邦迪斯血漿銅藍蛋白分析套組

Taiwan·Risk Class 2·MD·THE BINDING SITE GROUP LTD·Registered Oct 14, 2019 – Oct 14, 2024Expired

Registration details

Analysis ID: 044c0eb9032f46f884138bad11f31f33
License Form: Ministry of Health Medical Device Import No. 032938
Customs Code: DHA05603293803

Company information

Manufacturer: THE BINDING SITE GROUP LTD
Manufacturer Country: United Kingdom
Authorized Representative: EVERLIGHT BIOTECH(TAIWAN) CO., LTD.

Product details

Intended Use: This product is paired with the Binding Site Plite Analyzer for in vitro quantitative analysis of ceruloplasmin in human serum and heparin lithium salt plasma to help diagnose copper metabolism disorders.
Product Type (Level 1): C Immunology and microbiology devices
Product Type (Level 2): C5270 C-reactive protein immunoassay system
Import Information: Imported from abroad

Dates and status

Registration Date: Oct 14, 2019
Expiry Date: Oct 14, 2024

About this record

Access comprehensive regulatory information for The Binding Site Optilite Caeruloplasmin Kit in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 044c0eb9032f46f884138bad11f31f33 and manufactured by THE BINDING SITE GROUP LTD. The authorized representative in Taiwan is EVERLIGHT BIOTECH(TAIWAN) CO., LTD..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.